Gain(1)(q21) is an Unfavorable Genetic Prognostic Factor for Patients With Relapsed Multiple Myeloma Treated With Thalidomide but Not for Those Treated With Bortezomib.

Details

Language :

English

ISSN :

21522650

Volume :

13

Issue :

2

Database :

Complementary Index

Journal :

Clinical Lymphoma, Myeloma & Leukemia

Publication Type :

Academic Journal

Accession number :

92000963

Full Text :

https://doi.org/10.1016/j.clml.2012.11.012